Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T H Wasserman

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
Cancer Research|January 1, 1987
Relationship between the neurotoxicity of the hypoxic cell radiosensitizer SR 2508 and the pharmacokinetic profileC N Coleman, J Halsey, R S Cox, et al.
Cancer|February 15, 1993
Improved survival duration in patients with unresected solitary brain metastasis using accelerated hyperfractionated radiation therapy at total doses of 54.4 gray and greater. Results of Radiation Therapy Oncology Group 85-28B E Epstein, C B Scott, W T Sause, et al.
Radiology|September 1, 1985
Radiation fibrosis: differentiation from recurrent tumor by MR imagingH S Glazer, J K Lee, R G Levitt, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1987
A comparison of misonidazole sensitized radiation therapy to radiation therapy alone for the palliation of hepatic metastases: results of a Radiation Therapy Oncology Group randomized prospective trialS A Leibel, T F Pajak, V Massullo, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 1991
The Radiation Therapy Oncology Group: an update of clinical research activitiesT H Wasserman, T L Phillips, G E Hanks, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2001
Phase III randomized intergroup trial of subtotal lymphoid irradiation versus doxorubicin, vinblastine, and subtotal lymphoid irradiation for stage IA to IIA Hodgkin's diseaseO W Press, M LeBlanc, A S Lichter, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 1990
Accelerated fractionation radiation therapy for liver metastases: selection of an optimal patient population for the evaluation of late hepatic injury in RTOG studiesS A Leibel, C Guse, S E Order, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 23, 2001
Breast cancer occurred after treatment for Hodgkin's disease: analysis of 133 casesB Cutuli, C Borel, F Dhermain, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Cancer Research|January 1, 1987
Relationship between the neurotoxicity of the hypoxic cell radiosensitizer SR 2508 and the pharmacokinetic profileC N Coleman, J Halsey, R S Cox, et al.
Cancer|February 15, 1993
Improved survival duration in patients with unresected solitary brain metastasis using accelerated hyperfractionated radiation therapy at total doses of 54.4 gray and greater. Results of Radiation Therapy Oncology Group 85-28B E Epstein, C B Scott, W T Sause, et al.
Radiology|September 1, 1985
Radiation fibrosis: differentiation from recurrent tumor by MR imagingH S Glazer, J K Lee, R G Levitt, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1987
A comparison of misonidazole sensitized radiation therapy to radiation therapy alone for the palliation of hepatic metastases: results of a Radiation Therapy Oncology Group randomized prospective trialS A Leibel, T F Pajak, V Massullo, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 1991
The Radiation Therapy Oncology Group: an update of clinical research activitiesT H Wasserman, T L Phillips, G E Hanks, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2001
Phase III randomized intergroup trial of subtotal lymphoid irradiation versus doxorubicin, vinblastine, and subtotal lymphoid irradiation for stage IA to IIA Hodgkin's diseaseO W Press, M LeBlanc, A S Lichter, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 1990
Accelerated fractionation radiation therapy for liver metastases: selection of an optimal patient population for the evaluation of late hepatic injury in RTOG studiesS A Leibel, C Guse, S E Order, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 23, 2001
Breast cancer occurred after treatment for Hodgkin's disease: analysis of 133 casesB Cutuli, C Borel, F Dhermain, et al.
Pageof 9